|
Originally published In Press as doi:10.1074/jbc.M009645200 on September 19, 2001
J. Biol. Chem., Vol. 276, Issue 49, 46436-46444, December 7, 2001
Functional Role of Protein Kinase B/Akt in Gastric
Acid Secretion*
Andrea
Todisco ,
Nonthalee
Pausawasdi,
Saravanan
Ramamoorthy,
John
Del Valle,
Rebecca W.
Van Dyke, and
Frederick K.
Askari
From the Department of Internal Medicine, University of Michigan
Medical Center, Ann Arbor, Michigan 48109
Received for publication, October 23, 2000, and in revised form, September 13, 2001
 |
ABSTRACT |
Epidermal growth factor (EGF)
stimulates gastric acid secretion and
H+/K+-ATPase -subunit gene
expression. Because EGF activates the serine-threonine protein kinase
Akt, we explored the role of Akt in gastric acid secretion. Akt
phosphorylation and activation were measured by kinase assays and by
Western blots with an anti-phospho-Akt antibody, using lysates of
purified (>95%) canine gastric parietal cells in primary culture. EGF
induced Akt phosphorylation and activation, whereas carbachol had no
effect. LY294002, an inhibitor of phosphoinositide 3-kinase, completely
blocked EGF induction of Akt phosphorylation, whereas the MEK1
inhibitor PD98059 and the protein kinase C inhibitor GF109203X
had no effect. We examined the role of Akt in
H+/K+-ATPase gene expression by Northern
blotting using a canine H+/K+-ATPase
-subunit cDNA probe. The parietal cells were transduced with a
multiplicity of infection of 100 of the adenoviral vector Ad.Myr-Akt,
which overexpresses a constitutively active Akt gene, or with the
control vector Ad.CMV- -gal, which expresses
-galactosidase. Ad.Myr-Akt induced
H+/K+-ATPase -subunit gene expression
3-fold, whereas it failed to stimulate the gene cyclooxygenase-2, which
was potently induced by carbachol in the same parietal cells.
Ad.Myr-Akt induced aminopyrine uptake 4-fold, and it potentiated the
stimulatory action of carbachol 3-fold. In contrast, Ad.Myr-Akt failed
to induce changes in either parietal cell actin content, measured by
Western blots with an anti-actin antibody or in the organization of the
actin cellular cytoskeleton, visualized by fluorescein phalloidin
staining and confocal microscopy. Transduction of the parietal cells
with a multiplicity of infection of 100 of the adenoviral vector
Ad.dom.neg.Akt, which overexpresses an inhibitor of Akt, blocked the
stimulatory effect of EGF on both aminopyrine uptake and
H+/K+-ATPase production, measured by Western
blots with an anti-H+/K+-ATPase -subunit
antibody. Thus, EGF induces a cascade of events in the parietal cells
that results in the activation of Akt. The functional role of Akt
appears to be stimulation of gastric acid secretion through induction
of H+/K+-ATPase expression.
 |
INTRODUCTION |
Epidermal growth factor
(EGF)1 is the prototypic
member of a large family of peptide growth factors that are known to
exert numerous biological actions in the gut (1). In the stomach, EGF
affects acid secretion in a divergent fashion. Under acute conditions,
EGF has a long recognized inhibitory effect on acid secretion, whereas
prolonged administration of EGF increases both basal and maximal acid
secretion in vivo (2-5). Similar results have been observed
in vitro, using preparations of highly purified gastric
parietal cells in primary culture, which have been shown to express
specific receptors for EGF/transforming growth factor- (2, 4,
6, 7). In this system, prolonged exposure of the parietal cells to EGF
(>16 h) has been shown to enhance the stimulatory effects of
carbachol, gastrin, and histamine on gastric acid secretion (2, 4, 6).
The mechanisms responsible for this phenomenon are currently only
partially understood.
One hypothesis, based on in vivo observations, is that EGF
stimulates the proliferation of progenitor neck cells present in the
gastric glands, leading to an overall increase in the number of
acid-producing parietal cells present in the gastric mucosa (5).
Alternatively, recent studies performed both in isolated, cultured,
parietal cells and in AGS human gastric adenocarcinoma cells
have indicated that EGF is able to induce both the expression and the
transcription of the H+/K+-ATPase -subunit
gene (6, 8), suggesting that EGF might have a direct stimulatory effect
on the expression of the gene responsible for gastric acid production.
Little is known about the intracellular signal transduction mechanisms
that mediate the stimulatory effects of EGF on gastric acid production
and on H+/K+-ATPase -subunit gene
expression. Some studies, performed in isolated gastric parietal cells
in primary culture, have suggested that the stimulatory actions of EGF
on gastric acid secretion could be mediated by activation of the MAPK
signal transduction pathway because they can be fully reversed either
by genistein, a proteintyrosine kinase inhibitor, or by the MEK1
inhibitor, PD98059 (2, 9, 10).
However, another signal transduction pathway that has been recently
shown to play an important role in the mediation of some of the
physiological actions of EGF is that involving phosphoinositide 3-kinase (PI3K) and protein kinase B/Akt (11-14). Three major isoforms of Akt have been identified and described thus far (12, 14). Although
Akt 1 and Akt 2 are ubiquitously expressed, Akt 3 appears to be
expressed predominantly in the brain, heart, and kidney (12).
Activation of Akt is known to induce cellular growth and survival and
to promote the expression and the maintenance of highly differentiated
cellular phenotypes (11, 12, 15, 16). In addition, Akt has also been
shown to regulate the translocation of GLUT-4 to the plasma membrane
(12, 16) and to contribute to the regulation of vesicular trafficking
and endocytosis (12). Akt is homologous to the
cAMP-dependent protein kinase and PKC families of protein
kinases (12, 17). In vivo, the activity of Akt is regulated
by growth factors and serum through the induction of PI3K (12, 17, 18).
Phosphorylation of Akt appears to be critical for Akt activation (12,
17, 18). The major phosphorylation sites required for activation of Akt
1 have been identified as threonine 308 and serine 473, which are the
targets of the phosphoinositide-dependent kinases I and II,
respectively (12, 17). Similarly, Akt 2 and Akt 3 are also
phosphorylated on serine and threonine residues (Thr-309 and Ser-474 in
Akt 2 and Thr-305 and Ser-472 in Akt 3) by
phosphoinositide-dependent kinases I and II (12, 14).
Because little is known about the regulation and function of the
protein kinase Akt in the stomach, we undertook these studies to
examine the role of Akt in EGF-stimulated gastric acid production using highly purified gastric parietal cells in primary culture.
 |
MATERIALS AND METHODS |
Adenoviral Vectors--
The replication-defective adenoviral
vectors expressing wild type, HA-tagged Akt 1 (Ad.wt.Akt), dominant
negative HA-tagged, Akt 1 (with serine 473 and threonine 308 mutated to
alanine) (Ad.dom.neg.Akt), or HA-tagged, myristoylated, constitutively
active Akt 1 (Ad.Myr-Akt), under the control of the CMV promoter, were
gifts of K. Walsh (Tufts University, Boston, MA) (19). The adenoviral
vector expressing the -galactosidase enzyme under the control of the
CMV promoter (Ad.CMV- -gal) was described previously (20).
Primary Parietal Cell Preparation and Culture--
For
preparation of primary parietal cells we utilized a modification of the
method of Soll (21) and others (22-26). The mucosal layer of freshly
obtained canine gastric fundus was bluntly separated from the submucosa
and rinsed in Hanks' balanced salt solution containing 0.1% bovine
serum albumin. The cells were dispersed by sequential exposure to 0.35 mg/ml collagenase and 1 mM EDTA, and parietal cells were
enriched by centrifugal elutriation using a Beckman JE-6B elutriation
rotor. Our best preparations contained up to 70% parietal cells as
determined by hematoxylin and eosin and periodic acid-Shiff reagent
staining. The parietal cells are further purified by centrifugation
through density gradients generated by 50% Percoll (Amersham Pharmacia
Biotech) at 30,000 × g for 20 min. The cell fraction
at = 1.05 consists of virtually all parietal cells as
determined by staining with a specific mouse monoclonal antibody
against the hog H+/K+-ATPase -subunit (a
gift of A. Smolka, Charleston, SC) (26). The isolated parietal cells
(2 × 106 cells/well) are cultured according to the
methods of Ljungstrom and Chew (22) with some modifications (25, 26).
Briefly, the cells are cultured in Ham's F-12/Dulbecco's modified
Eagle's medium (1:1) containing 0.1 mg/ml gentamycin, 50 units/ml
penicillin G, and 2% dimethyl sulfoxide (Sigma) on 6-well culture
dishes (Corning Inc., Corning, NY) coated with 150 µl of
H2O-diluted (1:5) growth factor reduced Matrigel (Becton
Dickinson, Bedford, MA). For our studies, the parietal cells were
incubated with either EGF (Becton Dickinson)
(10 8-10 6 M) or carbachol
(Sigma) (10 4 M), for various time periods. In
some experiments PD98059 (5 × 10 5 M)
(New England Biolabs, Beverly, MA), GF109203X (3.5 × 10 6 M) (Calbiochem, La Jolla, CA), and
LY294002 (10 5 M) (Calbiochem) were added 30 min prior to the addition of the stimulants. PD98059, GF109203X, and
LY294002 were dissolved in dimethyl sulfoxide. All other test
substances were dissolved in water. The parietal cells were transduced,
when indicated, with a multiplicity of infection of 100 of the
adenoviral vectors expressing wild type Akt, dominant negative Akt,
constitutively active Akt, or -galactosidase for different time periods.
Northern Blot Analysis--
The parietal cells were lysed with
TRIzol (Life Technologies, Inc.) according to the manufacturer's
instructions. Northern blot hybridization assays were performed as
described previously (27). Equal amounts of each RNA sample, with
ethidium bromide (10 mg/ml) in a final volume of 20 µl, were
electrophoresed on a 1.25% agarose gel containing formaldehyde, and
the RNA was transferred from the gel to nitrocellulose filters. The
ethidium-stained ribosomal RNA bands in the gel were photographed
before and after transfer to ensure that equivalent amounts of RNA were
loaded onto each lane and that no residual RNA was left on the gel. The
canine H+/K+-ATPase -subunit and the human
cyclooxygenase-2 cDNA probes were gifts of I. Song and L. Crofford,
respectively (University of Michigan). The human
glyceraldehyde-3-phosphate dehydrogenase cDNA probe was obtained
from CLONTECH (Palo Alto, CA). The cDNAs were
labeled with [32P]dCTP by the random priming procedure,
and the nitrocellulose filters were hybridized to the
32P-labeled cDNA probes as described previously
(27).
Immunoprecipitations and Kinase Assays--
Immunoprecipitations
and kinase assays were performed according to techniques described
previously (26, 27) with minor modifications. The parietal cells were
lysed in 500 µl of lysis buffer (50 mM HEPES, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM
EDTA, 1.5 mM MgCl2, 1 mM
Na3VO4, 10 mM NaF, 10 mM Na4P2O7·10 H2O, 1 mM 4-(2-aminoethyl)
benzenesulfonylfluoridehydrochlorine (ICN-Biomedicals, Aurora, OH), 1 µg/ml leupeptin, and 1 µg/ml aprotinin). The lysates were
transferred into microcentrifuge tubes and spun at 16,000 × g for 20 min at 4 °C. Equal amounts of protein from
each treatment group (300 µg) were incubated with a monoclonal
anti-Akt kinase antibody immobilized on agarose beads and recognizing
all Akt isoforms (New England Biolabs). Protein concentrations were
measured by the Bradford method (28). After an overnight incubation at
4 °C, the solutions were centrifuged, and the pellets were washed
once with lysis buffer and twice with kinase buffer. Immunoprecipitated
Akt kinase was used to phosphorylate glycogen synthase kinase 3 .
GSK3 phosphorylation was measured by Western blots with a specific
anti-phospho-GSK3 / antibody. The reactions were carried
out according to the instructions of the Akt kinase assay kit from New
England Biolabs.
Western Blots--
For most blots, the parietal cells were lysed
as described previously under "Materials and Methods." For the
H+/K+-ATPase -subunit Western blots, the
parietal cells were lysed according to a different protocol (29).
Briefly, the cells were washed once in PBS and spun at 1500 RPM for 10 min at 4 °C. After removal of the supernatant, the pellets were
resuspended in 500 µl of homogenization buffer (10 mM
Pipes (Sigma) with Tris, pH 6.8, 0.25 M sucrose, 2 mM EDTA, 1 mM benzamidine, 10 µg/ml
leupeptin, 10 µg/ml pepstatin, and 1 µg/ml aprotinin). The
solutions were sonicated on ice (twice for 5 min each) (Braun). After
sonication, the samples were homogenized in 1-ml Dounce
micro-homogenizers (~15 strokes). The cell homogenates were spun at
1000 rpm for 5 min at 4 °C. The supernatants were transferred to
Eppendorf tubes. Protein concentrations were measured by the Bradford
method (28). 80 µg (5-10 µg for the
H+/K+-ATPase -subunit Western blots) of
parietal cell lysates were mixed with 5× electrophoresis buffer (for 5 ml: 2.5 ml of glycerol, 1.25 ml of 2-mercaptoethanol, 0.5 g of
SDS, 1.043 ml of 1.5 M Tris, pH 6.8, and 1.25 mg of
bromphenol blue), boiled for 5 min (except for the
H+/K+-ATPase -subunit Western blots, in
which the samples were not boiled), and loaded on 10%
SDS-polyacrylamide mini-gels that were run at 200 volts for 1 h.
The gels were transferred on an Immobilon-P transfer membrane
(Millipore, Bedford, MA) in 25 mM Tris, 150 mM
glycine, and 20% methanol. After transfer the membranes were blocked
in 10 ml of TBST (20 mM Tris, 0.15 M NaCl, and
0.1% Tween) and 5% dry milk for 1 h and then incubated for
16-18 h at 4 °C in 10 ml of TBST and 5% dry milk containing either
a specific anti-phospho-Akt antibody, which recognizes phosphorylated
serine 473 of Akt, or an anti-phospho-AFX antibody, which recognizes phosphorylated serine 193 of the transcription factor AFX (1:1000). Control blots were performed using antibodies recognizing all isoforms
of Akt kinase independent of their phosphorylation states (1:1000) (New
England Biolabs). For the H+/K+-ATPase
-subunit Western blots the membranes were incubated for 16-18 h at
4 °C in TBST and 5% dry milk containing a specific mouse monoclonal
antibody against the hog H+/K+-ATPase
-subunit (26) antibody (1:5000). In some experiments the membranes
were incubated for 16-18 h at 4 °C in 10 ml of TBST and 5% dry
milk, containing 20 µg of a monoclonal anti-actin antibody (Santa
Cruz Biotechnology, Santa Cruz, CA). For the GSK3 phospho-blots, the
membranes were incubated for 16-18 h at 4 °C in 10 ml of TBST and
5% bovine serum albumin (Sigma) containing a monoclonal
anti-phospho-GSK3 / antibody (1:1000) that recognizes
phosphorylated serine 21 of GSK3 and phosphorylated serine 9 of
GSK3 , (New England Biolabs). At the end of the incubation periods
the membranes were washed in TBST for 30 min at room temperature and
then incubated for 1 h in TBST and 5% dry milk containing either
protein A directly conjugated to horseradish peroxidase (Amersham
Pharmacia Biotech) (1:2500) for the Akt and the AFX blots or an
horseradish peroxidase-conjugated anti-rabbit secondary antibody
(1:2000) for the GSK3, actin, and H+/K+-ATPase
-subunit blots. The membranes were washed in TBST for 30 min at room
temperature and then exposed to the Amersham ECL detection system
according to the manufacturer's instructions.
Amplification and Purification of Adenoviral
Vectors--
Briefly, the recombinant adenoviruses were amplified as
described previously using 293 cells (20). The viruses were
subsequently concentrated and purified on a cesium chloride gradient
(20). The concentration of the recombinant adenoviruses was assessed on
the basis of the absorbency at 260 nm and on a limiting dilution plaque
assay (20).
Immunohistochemistry--
The parietal cells were transduced
with the adenoviral vectors expressing HA-tagged dominant negative Akt,
HA-tagged Myr-Akt, or HA-tagged wt-Akt or with the adenoviral vectors
expressing the -galactosidase enzyme and cultured on slides for
16-18 h. At the end of the incubation period the cells were fixed in
4% formalin-PBS. The slides were blocked for 30 min with 20% donkey serum and incubated for 2 h with a mouse monoclonal anti-HA
antibody (1:500) (Babco Berkeley Antibody Co., Richmond, CA).
The cells were then rinsed with PBS, and a 1:150 dilution of a
FITC-conjugated donkey anti-mouse IgG secondary antibody (Jackson
Immunoresearch Laboratories, West Grove, PA) was added for 1 h.
After a wash with PBS, the cells were mounted in Vectashield (Vector
Laboratories, Burlingame, CA) and visualized by confocal fluorescence
microscopy. In some experiments the parietal cells were incubated with
the FITC-conjugated secondary antibody without the primary antibodies. The percentage of parietal cells expressing the HA-tagged virally expressed Akt proteins was calculated by examining both the
differential interference contrast and the immunofluorescence images of
transduced parietal cells in three fields of each slide.
Actin Staining by Fluorescein Phalloidin in Isolated Gastric
Parietal Cells--
After either stimulation with carbachol or
transduction with the adenoviral vectors, the parietal cells were fixed
by treatment with 4% formaldehyde in PBS for 10 min at room
temperature. After a PBS wash, the cells were permeabilized by
incubation in 0.2% Triton X-100 in PBS for 10 min at room temperature
and blocked with three sequential 5-min incubations in PBS containing
1% bovine serum albumin and 0.2% Triton X-100. Actin was detected by
incubation of the cells for 20 min in fluorescein phalloidin (Molecular
Probes, Eugene, OR) in 1% bovine serum albumin with PBS at 4 °C.
After three washes with PBS, the parietal cells were mounted in
Vectashield (Vector Laboratories, Burlingame, CA) and visualized by
confocal fluorescence microscopy. In control experiments the cells were incubated with PBS without fluorescein phalloidin.
Detection of Adenoviral Delivered -Galactosidase--
For
identification of parietal cells transduced with the adenoviral vector
expressing -galactosidase, the cells were cultured on slides for
16-18 h and stained with X-gal after 24 h of infection. The cells
were washed with PBS and then fixed in 0.5% glutaraldehyde at room
temperature for 10 min. After two washes with 1 mM
MgCl2 in PBS, the cells were incubated overnight at
37 °C in a solution consisting of 5 mM
K3Fe(CN)6, 5 mM
K4Fe(CN)6, and 2 mM
MgCl2 in PBS with 0.1% X-gal. At the end of the
incubation, the cells were rinsed with PBS and observed with a light
transmission microscope.
Aminopyrine Uptake--
Gastric acid secretion was measured
according to methods described previously (2, 6, 9). Briefly, the
accumulation of the weak base [14C]aminopyrine (Amersham
Pharmacia Biotech) was used as an indicator of acid production by
parietal cells. Both infected and noninfected cultured parietal cells
were washed once with Earle's balanced salt solution, incubated with
0.1 µCi of [14C]aminopyrine for 60 min, and then
stimulated, when indicated, with carbachol (10 4
M) for the last 30 min of aminopyrine incubation. In some
experiments, the cells were cultured for 16-18 h in the presence of
EGF (10 8 M) either alone or in combination with
LY294002 (10 5 M), prior to the addition of
carbachol. The parietal cells were lysed with 500 µl of 1% Triton
X-100, and the radioactivity of lysate was quantified in a liquid
scintillation counter as previously reported (6, 9).
Data Analysis--
The data are expressed as the means ± S.E. Statistical analysis was performed using Student's t
test. p values < 0.05 were considered to be significant.
 |
RESULTS |
We examined the effect of EGF on Akt phosphorylation using Western
blots with a specific anti-phospho-Akt antibody directed against
Ser(P)-473. As shown in Fig. 1, EGF
stimulated Akt phosphorylation, with a maximal effect detected after 5 min of incubation at doses ranging between 10 8 and
10 6 M. Akt activation returned to base line
after prolonged exposure to EGF (30-60 min (Fig. 1) and 24 h
(data not shown)). By contrast, the cholinergic agonist carbachol
(10 4 M) failed to have any effect (Fig.
2A). Total Akt levels were not
changed by any of the treatments.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
EGF stimulates Akt phosphorylation.
Phosphorylation of Akt kinase in lysates from Percoll-purified,
cultured parietal cells stimulated for 5, 30, and 60 min with EGF
(10 8-10 6 M) was studied by
Western blots using a specific anti-phospho-Akt antibody. Total Akt
kinase levels were monitored by Western blots with an antibody
recognizing Akt kinase independent of its phosphorylation state.
Identical results were obtained in at least three other separate
experiments.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 2.
Signal transduction pathways regulating Akt
phosphorylation. Phosphorylation of Akt kinase in lysates from
Percoll-purified, cultured parietal cells stimulated for 5 min with
either carbachol (10 4 M) or EGF
(10 8 M) (A) alone or in
association with LY294002 (10 5 M)
(B), PD98059 (5 × 10 5 M)
(C), or GF109203X (3.5 × 10 6
M) (C) was studied by Western blots using a
specific anti-phospho-Akt antibody. Total Akt kinase levels were
monitored by Western blots with an antibody recognizing Akt kinase
independent of its phosphorylation state. Identical results were
obtained in at least three other separate experiments.
|
|
To confirm that phosphorylation of Akt correlated with Akt activation,
we examined the effect of EGF (10 8 M) on Akt
activity measured by an in vitro kinase assay using GSK3
as substrate. GSK3 phosphorylation was quantitated by Western blots
with a specific anti-phospho-GSK3 / antibody. EGF exposure for 5 min induced Akt activation, but it did not alter the amount of
total Akt immunoprecipitated from the cell lysates (data not shown).
Because activation of PI3K is thought to be an important step in Akt
activation, we examined whether EGF induction of Akt phosphorylation,
required PI3K activity. EGF-stimulated Akt phosphorylation was
inhibited by 10 5 M LY294002 (Fig.
2B), a specific and well characterized inhibitor of PI3K,
indicating that in the gastric parietal cells, EGF targets Akt through
PI3K-dependent signaling pathways. In contrast, both the
MAPK inhibitor PD98059 (5 × 10 5 M) and
the PKC inhibitor GF109203X (3.5 × 10 6
M) failed to have any effect on EGF-stimulated Akt
phosphorylation (Fig. 2C).
To examine the role of Akt on H+/K+-ATPase gene
expression and on gastric acid production, we transduced the gastric
parietal cells for 18 h with a multiplicity of infection of 100 of
the adenoviral vectors expressing either a hemagglutinin-tagged
myristoylated, constitutively active form of Akt or a
hemagglutinin-tagged dominant negative Akt gene. Control experiments
were performed with the adenoviral vector Ad.CMV- -gal, which
expresses -galactosidase. Noninfected cells did not stain with X-gal
(Fig. 3A). In contrast, as
shown in Fig. 3B, histochemical staining for
-galactosidase demonstrated that more than 80% of the parietal
cells were transduced with the adenoviral vector expressing
-galactosidase. To document expression of both dominant negative and
of constitutively active Akt, parietal cells transduced with either
Ad.dom.neg.Akt or Ad.Myr-Akt, were stained with an
anti-hemagglutinin primary antibody and a FITC-conjugated secondary
antibody. Eighteen to twenty 1-µm-thick z sections of parietal cells
from three different fields of one slide of transduced cells were
analyzed by confocal microscopy to examine the localization of the
virally expressed kinases. As indicated by the representative images
shown in Fig. 3, hemagglutinin-tagged dominant negative Akt (Fig.
3D) and hemagglutinin-tagged myristoylated Akt (Fig.
3F) were expressed in the parietal cells. Dominant negative Akt-transduced and myristoylated Akt-transduced parietal cells exhibited similar morphology. Both isoforms of virally expressed Akt
appeared to be predominantly localized at the level of the plasma
membrane, although cytoplasmic staining was also apparent in some
preparations, particularly in the case of the dominant negative Akt
protein (data not shown). Ad.CMV- -gal-transduced parietal cells
stained with the anti-hemagglutinin primary antibody and the
FITC-conjugated secondary antibody showed no significant cell membrane
staining (Fig. 3H). The nonspecific perinuclear punctate
staining noted in these cells most likely represented autofluorescence
of lipofuscin in lysosomes, as described previously in epithelial cells
in culture (30). The percentage of parietal cells transduced with the
adenoviral vectors expressing dominant negative and myristoylated Akt
varied between 50 and 80%, depending on the preparation. The data
represented in Fig. 3 (D and F) indicate that
more than 50% of the cells were successfully transduced. Similar
results were observed when the parietal cells were transduced with the
adenoviral vector Ad.wt.Akt, which overexpresses a
hemagglutinin-tagged wild type Akt protein (data not shown). Expression
of the hemagglutinin-tagged virally expressed Akt kinases was also
demonstrated by Western blot analysis of lysates from parietal cells
transduced with either Ad.dom.neg.Akt or Ad.Myr-Akt using the anti-HA
antibody (data not shown). Time course studies showed that expression
of HA-tagged dom.neg.Akt was detectable as early as 1 h after
infection (data not shown).

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 3.
Transduction of cultured gastric parietal
cells with adenoviral vectors. Histochemical staining for
-galactosidase of nontransduced (A) and
Ad.CMV- -gal-transduced (B) Percoll-purified, cultured
gastric parietal cells. Parietal cells transduced with either
Ad.dom.neg.Akt or with Ad.Myr-Akt and stained with a mouse monoclonal
primary anti-HA antibody and a donkey anti-mouse FITC-conjugated
secondary antibody are shown in D and F,
respectively. Control parietal cells transduced with Ad.CMV- -gal and
incubated with the mouse monoclonal primary anti-HA antibody and the
donkey anti-mouse FITC-conjugated secondary antibody are shown in
H. Images are representative 1-µm confocal fluorescence
sections. Corresponding differential interference contrast images are
shown in C, E, and G. The
arrows indicate specific staining of the surface plasma
membrane with the anti-HA antibody. Magnification, 20× in
A and B and 63× in C-H.
Bars, 50 µm in A and B and 10 µm
in D, F, and H. Similar results were
obtained in two other separate experiments.
|
|
H+/K+-ATPase mRNA was isolated from the
parietal cells and quantitated by Northern blot analysis using a canine
H+/K+-ATPase -subunit cDNA probe. The
autoradiograms were controlled for RNA quantity by hybridization of the
RNA with a glyceraldehyde-3-phosphate dehydrogenase cDNA probe. In
agreement with previously published observations (6), stimulation of
the parietal cells with EGF (10 8 M) for
either 7 or 16 h induced canine
H+/K+-ATPase -subunit gene expression in
these gastric parietal cells (data not shown). Transduction of the
parietal cells with the adenoviral vector expressing constitutively
active Akt for either 7 h (data not shown) or 18 h, induced
H+/K+-ATPase -subunit gene expression
3-fold, whereas no effect was observed in the presence of the control
vector expressing -galactosidase (Fig.
4, A and B).
Similar results were observed in Western blots with a specific
anti-H+/K+-ATPase -subunit antibody,
suggesting that Akt increases both the
H+/K+-ATPase gene and protein in the gastric
parietal cells (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Akt regulates
H+/K+-ATPase -subunit
gene expression. Aliquots of total RNA (10 µg) extracted
following infection of Percoll-purified, cultured parietal cells for
18 h with either Ad.Myr-Akt or with Ad.CMV- -gal were examined
by Northern blot analysis using a 32P-labeled cDNA
probe for the H+/K+-ATPase -subunit gene
(A). B, results obtained from densitometric
analysis of H+/K+-ATPase -subunit Northern
blots derived from several parietal cell preparations. The data are
expressed as fold induction over control (means ± S.E.).
O.D., optical density. The numbers in
parentheses indicate the number of times each experiment was
repeated. Aliquots of total RNA (10 µg) extracted following
either infection of the cultured parietal cells for 18 h with the
adenoviral vectors (C) or after stimulation for 2 h
with 10 4 M carbachol (D) were
examined by Northern blot analysis using 32P-labeled
cDNA probes for either the H+/K+-ATPase
-subunit gene or cyclooxygenase-2. The data were reproduced in at
least one other separate experiment. The autoradiograms were controlled
for RNA quantity by hybridization of the RNA with a cDNA probe
encoding the ubiquitous enzyme glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
|
|
To confirm the specificity of this observation, we examined the effect
of Akt on the expression of the highly inducible gene cyclooxygenase-2.
Transduction of the parietal cells for 18 h with the adenoviral
vector expressing constitutively active Akt failed to stimulate
cyclooxygenase-2 gene expression (Fig. 4C), which, in
contrast, was potently induced by stimulation of parietal cells from
the same preparation with carbachol (10 4 M) for
2 h (Fig. 4D). In addition, stimulation with EGF
(10 8 M) for 30 min, 2 h, and 24 h
failed to induce cyclooxygenase-2 gene expression in the gastric
parietal cells (data not shown). These results indicate that Akt exerts
specific stimulatory effects on H+/K+-ATPase
gene expression in the gastric parietal cells.
To examine the functional significance of Akt in gastric
acid secretion, we tested the effect of Akt on
[14C]aminopyrine uptake. In agreement with previously
published observations (2), carbachol led to a 5-fold, statistically
significant induction in [14C]aminopyrine uptake (Fig.
5). Carbachol also significantly induced [14C]aminopyrine uptake in both Ad.CMV- -gal-transduced
and Ad.Myr-Akt-transduced parietal cells, indicating that the
adenoviral vectors did not alter the function of the parietal cells. In
addition, transduction of the cells for 18 h with the adenoviral
vector expressing constitutively active Akt induced basal
aminopyrine uptake 4-fold and, like EGF, led to a statistically
significant enhancement of the stimulatory action of carbachol (Fig.
5). Even modestly active Akt potentiated acid secretion as shown in
additional experiments performed using the adenoviral vector Ad.wt.Akt.
This vector overexpresses a wild type Akt protein that has been shown
to exhibit a low level of kinase activity and to respond to
physiological stimuli (19, 31). Transduction of the parietal cells for
18 h with Ad.wt.Akt led to a modest induction in
H+/K+-ATPase gene expression (data not shown).
Ad.wt.Akt also stimulated basal aminopyrine uptake by only 1.38-fold
(1602 cpm ± 813.23 in the presence of Ad.CMV- -gal
versus 2214.5 ± 893.55 cpm in the presence of
Ad.wt.Akt, means ± S.E., n = 6) compared with the
effects of Ad.Myr.Akt, yet, like EGF, it enhanced the stimulatory action of carbachol on acid secretion by 30% (data not shown). Thus,
activation of Akt appears to be important for stimulation of gastric
acid production.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of adenoviral vectors on
[14C]aminopyrine uptake. Percoll-purified cultured,
canine gastric parietal cells were incubated for 30 min with
10 4 M carbachol after infection for 18 h
with either Ad.Myr-Akt or with Ad.CMV- -gal. The data are expressed
as cpm (means ± S.E.). the numbers in
parentheses indicate the number of times each experiment was
repeated. *, p < 0.05.
|
|
To confirm the involvement of Akt in the stimulatory action of EGF on
gastric acid secretion, we transduced the gastric parietal cells with
an adenoviral vector expressing dominant negative Akt and measured
[14C]aminopyrine uptake. Transduction of the gastric
parietal cells with dominant negative Akt did not affect basal
[14C]aminopyrine uptake, but it blocked the stimulatory
action of EGF on carbachol-induced increase in
[14C]aminopyrine uptake (Fig.
6).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of Ad.dom.neg.Akt on EGF enhancement
of gastric acid secretion. Percoll-purified, cultured, canine
gastric parietal cells were infected for 18 h with either
Ad.dom.neg.Akt or with Ad.CMV- -gal and incubated for 30 min with
10 4 M carbachol, alone or after preincubation
for 16 h with 10 8 M EGF. The data are
expressed as fold induction over control (means ± S.E.). The
numbers in parentheses indicate the number of
times each experiment was repeated. *, p < 0.05.
|
|
Because EGF appeared to target Akt through PI3K-dependent
signaling pathways (Fig. 2B), we examined the effect of
LY294002 on the stimulatory action of EGF on carbachol-induced gastric acid secretion. As shown in Fig. 7,
preincubation of the parietal cells with LY294002 completely reversed
the stimulatory effect of EGF on [14C]aminopyrine uptake,
suggesting that EGF requires the sequential activation of PI3K and Akt
kinase to regulate gastric acid production.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
LY294002 inhibits EGF enhancement of gastric
acid secretion. Percoll-purified, cultured, canine gastric
parietal cells were incubated for 16 h with 10 5
M LY294002 or for 30 min with 10 4
M carbachol, alone or after preincubation for 16 h
with 10 8 M EGF in the presence or absence of
10 5 M LY294002. The data are expressed as
fold induction over control (means ± S.E.). The
numbers in parentheses indicate the number of
times each experiment was repeated. *, p < 0.05.
|
|
To further demonstrate that EGF stimulation of gastric acid secretion
is mediated by increased production of the
H+/K+-ATPase through an
Akt-dependent mechanism, we performed Western blots with a
specific anti-H+/K+-ATPase -subunit
antibody. As shown in Fig. 8, EGF
stimulated the production of the H+/K+-ATPase
-subunit, whereas dominant negative Akt inhibited this effect. Thus,
EGF induces Akt to regulate H+/K+-ATPase
production and gastric acid secretion in the gastric parietal cells.

View larger version (6K):
[in this window]
[in a new window]
|
Fig. 8.
EGF induces the production of the
H+/K+-ATPase.
H+/K+-ATPase -subunit expression in lysates
from Percoll-purified, cultured parietal cells transduced for 18 h
with either Ad.dom.neg.Akt or with Ad.CMV- -gal and treated for
16 h with 10 8 M EGF was studied by Western
blots with an anti-H+/K+-ATPase -subunit
antibody. Identical results were obtained in two other separate
experiments.
|
|
Actin and the actin cytoskeleton are thought to play an important role
in the regulation of gastric acid secretion (2). Furthermore, gastrin,
carbachol, and histamine have been shown to induce actin gene
expression (2, 23). Accordingly, we investigated whether Akt altered
the amount or organization of actin in the gastric parietal cells. As
indicated in the Western blot shown in Fig.
9, transduction of the parietal cells for
18 h with Ad.Myr-Akt failed to change actin protein content,
although Ad.Myr-Akt was active in the same cells as the forkhead
transcription factor AFX, a known substrate of Akt (12, 32) was heavily phosphorylated.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 9.
Akt does not regulate actin expression in the
gastric parietal cells. Actin expression in lysates from
Percoll-purified, cultured parietal cells transduced for 18 h with
either Ad.Myr-Akt or with Ad.CMV- -gal was studied by Western blots
with an anti-actin antibody. Control blots were performed using an
anti-phospho-AFX antibody. Identical results were obtained in one other
separate experiment.
|
|
We also examined the role of Akt in the organization of the actin
cytoskeleton. For these studies, gastric parietal cells were stained
with fluorescein phalloidin. Eighteen to twenty 1-µm-thick z sections
of parietal cells from three different fields of one slide of cultured
cells were analyzed by confocal microscopy. As shown in the
representative images depicted in Fig.
10, treatment of the cells with
10 4 M carbachol for 2 h induced profound
changes in the organization of the actin cytoskeleton, characterized by
the fusion of the small intracellular canaliculi (Fig. 10A)
into larger canalicular structures, as it has been demonstrated by
other investigators (Fig. 10B) (33). In contrast,
transduction of parietal cells with Ad.CMV- -gal (Fig.
10C), Ad.Myr-Akt (Fig. 10D), or Ad.dom.neg.Akt (Fig. 10E) for 18 h failed to induce significant
changes in the organization of the actin cytoskeleton. Transduction of
parietal cells obtained from the same dog preparations with Ad.Myr-Akt led to a significant increase in aminopyrine uptake (data not shown),
indicating that the cells were transduced with an active preparation of
the adenoviral vector. The specificity of the fluorescent staining was
demonstrated by incubation of the parietal cells with PBS without
fluorescein phalloidin (Fig. 10F). Thus, activation of Akt
alone does not lead to reorganization of the actin cytoskeleton in
these isolated parietal cells.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 10.
Akt does not regulate the organization of
the actin cytoskeleton in the gastric parietal cells. Images
of actin staining by fluorescein phalloidin of Percoll-purified,
cultured parietal cells that were left untreated (A),
stimulated for 2 h with 10 4 M carbachol
(B), or transduced for 18 h with Ad.CMV- -gal
(C), Ad.Myr-Akt (D), or Ad.dom.neg.Akt
(E) are shown. Control parietal cells incubated with PBS
without fluorescein phalloidin are shown in F. The
arrows indicate the intracellular canaliculi. The images are
representative 1-µm confocal fluorescence sections. Magnification,
100×. Bar, 10 µm. Identical results were obtained in two
other separate experiments.
|
|
 |
DISCUSSION |
Gastric acid secretion is a complex biological process that
involves the coordinated interaction of hormones, growth factors and
neurotransmitters (2). The importance of carbachol, gastrin, and
histamine as stimulants of gastric acid secretion has been confirmed in
studies with isolated gastric parietal cells (2). These agents are
known to trigger a complex cascade of intracellular events that leads
to parietal cell activation and gastric acid production (2, 23).
Several investigations have demonstrated that the resting parietal
cells are characterized by the presence of a collapsed canalicular
system and of cytoplasmic tubulovesicles containing the gastric proton
pump, H+/K+-ATPase. Upon stimulation with the
gastric acid secretagogues for as little as 20 min, the parietal cells
rapidly develop an intracellular canalicular system bulging with
microvilli with concomitant fusion of the tubulovesicles with the
canaliculi (2, 33). This fusion translocates the
H+/K+-ATPase from the vesicular membranes to
the apical plasma membrane, where it actively pumps H+ ions
in exchange for K+ (2).
Of the different acid secretagogues, carbachol is the most potent
inducer of gastric acid secretion in the canine parietal cells. The
signal transduction pathways that mediate this action of carbachol have
been the focus of numerous investigations (2, 9, 22). In particular,
mobilization of intra- and extracellular calcium appears to be a
crucial event for carbachol induction of acid secretion. The specific
intracellular targets of these calcium-dependent signal
transduction pathways have been, to date, poorly characterized.
In addition to carbachol, gastrin, and histamine, numerous other agents
are known to regulate the secretory activity of the parietal cells (2).
EGF, in particular, is known to interact with specific EGF receptors
present on the parietal cells to modulate gastric acid production (2,
7). Several studies conducted in isolated and cultured parietal cells
have indicated that EGF has a rapid inhibitory effect on gastric acid
secretion that appears to be mediated by activation of PKC (3). In
contrast, prolonged incubation of the cells (>16 h) with EGF leads to
enhancement of the stimulatory action of carbachol, gastrin, and
histamine on gastric acid production (2, 4, 5, 6, 9). Additional investigations have suggested that EGF enhancement of
secretagogue-stimulated gastric acid secretion might reflect the
ability of EGF to induce the expression of the
H+/K+-ATPase gene (6). A study performed in the
canine parietal cells has demonstrated that EGF is able to induce the
transcription of the -subunit of the
H+/K+-ATPase gene through a novel EGF response
element located between bases 162 and 156 (5'-GACATGG-3') relative
to the cap site (6). This EGF response element was found to be
homologous to the 3'half-site of the c-fos serum response element.
Because Akt is known to exert numerous important physiological
functions and to mediate some of the intracellular effects of EGF (13,
14), we explored the possibility that Akt could be one of the kinases
that participate in the complex series of events that mediate the
stimulatory action of EGF on H+/K+-ATPase gene
expression and gastric acid production. In this study, we reported that
EGF potently stimulates Akt activation in the gastric parietal cells.
In addition, although in the parietal cells EGF induces both MAPK and
PKC, we showed that EGF stimulates Akt through PKC- and
MAPK-independent signaling pathways. In fact, neither the PKC inhibitor
GF109203X nor the MEK1 inhibitor PD98059 had any effect on EGF
stimulation of Akt activation. These observations are in agreement with
other studies that have indicated that MAPK is not involved in the
activation of Akt (34). Although the role of PKC in Akt activation has
been poorly characterized (35), our results suggest that
GF109203X-sensitive PKC isoforms do not play any role in the regulation
of Akt in the parietal cells. In contrast, we confirmed the involvement
of PI3K-dependent signal transduction pathways, because the
PI3K inhibitor LY294002 completely blocked EGF stimulation of Akt activation.
We also reported that carbachol alone does not induce Akt in the
gastric parietal cells, whereas it potently activates this kinase in
the PC-12 cells (36). This observation suggests the presence of cell
type-specific differences regarding the ability of muscarinic receptors
to induce the Akt signal transduction pathway. Furthermore, this
finding indicates that induction of Akt is a signaling event that is
specifically activated by EGF but not carbachol.
To analyze the functional significance of Akt activation in the
parietal cells, we took advantage of adenoviral vectors expressing the
wild type, constitutively active, or dominant negative forms of Akt.
Using immunocytochemistry and confocal microscopy, we confirmed that
these molecules could be effectively delivered to the parietal cells.
As expected, the constitutively active Akt protein, which contains a
myristoylation sequence, was expressed mostly at the level of the
surface membrane. Although they lacked a specific membrane localization
signal, both the wild type and the dominant negative Akt proteins were
also predominantly localized at the level of the plasma membrane. We
hypothesize that this observation might be the result of the high
intracellular level of expression of both dominant negative and wild
type Akt achieved by the CMV promoter.
In this study we reported that transduction of the parietal cells with
Ad.Myr-Akt led to readily detectable increases in both H+/K+-ATPase gene expression and gastric acid
production. We also demonstrated that EGF increases the level of the
H+/K+-ATPase protein through a signal
transduction pathway that is inhibited by Ad.dom.neg.Akt. These
observations together with the finding that both LY294002 and
Ad.dom.neg.Akt block the stimulatory effect of EGF on gastric acid
production strongly support a role for Akt in EGF regulation of gastric
acid secretion.
The actin cytoskeleton is an important element in
secretagogue-stimulated gastric acid secretion, because during this
process the parietal cell undergoes dramatic morphological
modifications (2). In addition, studies conducted in the canine
parietal cells have shown that the gastric acid secretagogues are able to induce the gene encoding actin, which is required for the cellular morphological transformations involved in the acid secretory process (2, 23). Accordingly, we explored the possibility that Akt might
regulate the expression and the organization of actin in the gastric
parietal cells. Although we were able to reproduce the well
characterized changes in the organization of the actin cytoskeleton
that occur in response to stimulation of the parietal cells with
gastric acid secretagogues (2, 33, 37), we did not detect any
morphological differences between untreated parietal cells and cells
that were transduced with Ad.Myr-Akt. Similarly, we did not observe any
changes in actin expression in Ad.Myr-Akt-transduced gastric parietal
cells. On the basis of these observations, we suggest that although Akt
induces the H+/K+-ATPase and stimulates gastric
acid production, these effects are not mediated by changes in the
expression and organization of actin in the parietal cells.
Interestingly, similar findings were recently reported in L6 myoblasts
(38), pig aortic endothelial cells (39), and SKF5 neuroectodermal cells
(40) in which actin remodeling and reorganization were not mediated by
the activation of Akt.
Although Akt appears to be one of the signal transduction pathways that
mediate the stimulatory action of EGF on gastric acid secretion, we
noted that transduction of the parietal cells with Ad.Myr-Akt did not
completely mimic the effects of EGF or carbachol alone. In fact, we
observed that Ad.Myr-Akt by itself markedly increased acid secretion,
as does carbachol, whereas EGF did not. Further, although Ad.Myr-Akt
alone increased aminopyrine uptake, it failed to influence the
organization of the actin cytoskeleton, which, in contrast, was
significantly affected by treatment of the parietal cells with
carbachol. Accordingly, regulation of gastric acid secretion in
response to stimulation of the gastric parietal cells with growth
factors and neurotransmitters appears to require the activation of a
complex network of signal transduction pathways.
One possible explanation for the stimulatory effect of Ad.Myr-Akt on
basal gastric acid secretion might involve differences in the intensity
and duration of Akt activation by EGF and Myr-Akt. Overexpression of
Akt and stimulation of H+/K+-ATPase gene
expression by the virus could lead to a situation of
"overproduction" of the H+/K+-ATPase with
saturation of the intracellular membranes and insertion of an increased
number of proton pumps to the apical plasma membrane under basal
conditions. In contrast, the canine parietal cell EGF receptor might be
responsible for a lower level of Akt activation that can induce the
H+/K+-ATPase and enhance
secretagogue-stimulated gastric acid production but is not able to
affect basal gastric acid secretion to a level detectable by currently
available methods. In support of this hypothesis, we observed that
transduction of the parietal with the adenoviral vector Ad.wt.Akt,
which overexpresses a wild type Akt protein with a low level of kinase
activity (19, 31), had only a modest stimulatory effect on both
H+/K+-ATPase gene expression and basal gastric
acid secretion. Interestingly, in some experiments, we noted that EGF
by itself could lead to modest, although not reproducible, increases in
basal aminopyrine uptake (1.3-1.5-fold; data not shown), suggesting
that depending on the preparation, EGF, by itself, could exhibit a
small stimulatory effect on gastric acid secretion. Furthermore, in
contrast to what we observed in the dog, in the rabbit EGF alone has
been shown to exhibit a modest, albeit statistically significant effect on aminopyrine uptake (4), supporting the notion that EGF alone can
regulate gastric acid production in the gastric parietal cells.
This study also demonstrates that carbachol-stimulated acid secretion
is mediated by several interacting processes, only some of which are
affected by the EGF/Akt signal transduction pathway. Our observations
suggest that carbachol-induced insertion of the H+/K+-ATPase on the apical membranes of the
parietal cells could be enhanced in cells that posses more
H+/K+-ATPase molecules, such as those exposed
to EGF or transduced with either Ad.wt.Akt or Ad.Myr-Akt. However, it
is clear that carbachol stimulates actin rearrangement through an
EGF/Akt-independent mechanism. Maximal stimulation of gastric acid
secretion appears to require both processes.
We have previously reported that activation of the parietal cell EGF
receptor induces MAPK and that incubation of the parietal cells with
the MEK1 inhibitor PD98059 leads to a complete reversal of EGF
enhancement of carbachol-stimulated gastric acid secretion (9).
Accordingly, it appears that multiple signal transduction pathways
could be involved in the stimulatory effect of EGF on gastric acid
production. Although a direct link between induction of MAPK and
stimulation of the H+/K+-ATPase gene has not
been demonstrated, it is possible that this gene might receive input
from signaling pathways involving both Akt and MAPK. It is clear that
additional studies are necessary to examine in more detail the relative
contribution of MAPK and Akt in the mediation of the stimulatory action
of EGF on H+/K+-ATPase gene expression.
Akt is known to induce the expression of highly specialized cellular
phenotypes (12, 15, 16). In particular, Akt has been shown to play an
important role in the complex process of myogenesis and muscle
differentiation (15). Similarly, expression of constitutively active
forms of Akt can induce the differentiation of 3T3-L1 fibroblasts into
adipocytes (16). Another important function of Akt is to promote cell
survival (12) through its ability to phosphorylate proteins such as
forkhead/winged helix transcription factors (13, 32, 41), bad (12, 34,
42), and caspase-9 (43) that appear to play an important role in the
induction of apoptosis. Accordingly, the ability of Akt to induce the
expression of the H+/K+-ATPase gene might also
represent a more generalized effect of this kinase on parietal cell
differentiation and survival. It is possible that induction of Akt
might be an important signal transduction pathway activated by the
parietal cell EGF receptor to promote cellular differentiation and to
inhibit apoptosis.
In conclusion, we have demonstrated that in the parietal cells, EGF
regulates the expression of the H+/K+-ATPase
through a signal transduction pathway that involves the activation of
Akt. These findings suggest a novel role for Akt in the regulation of
the secretory function of the gastric parietal cells, and they shed new
insight into the molecular mechanisms that regulate the complex process
of gastric acid secretion.
 |
ACKNOWLEDGEMENTS |
We thank Jung Park for assistance with
parietal cells preparation, Thomas Witham, Marianne Lewis, Daniel
Miller, and Jace Nielsen for technical assistance, and Chris Edwards
and the University of Michigan Microscopy and Image-analysis
Laboratory for assistance with confocal microscopy.
 |
FOOTNOTES |
*
This work was supported by NIDDK, National Institutes of
Health Grant RO1-DK-058312 (to A. T.), as well as funds from
National Institutes of Health Grant P30DK34933 to the University of
Michigan Gastrointestinal Peptide Research Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of an American Gastroenterological Association Industry
Research Scholar Award, a Clinical Investigator Award from the National
Institutes of Health (National Institutes of Health Grant K08DK02336),
and a grant from the Charles E. Culpeper Foundation Health Program. To
whom correspondence should be addressed: 6520 MSRB I, Ann Arbor, MI
48109-0682. Tel.: 734-647-2942; Fax: 734-763-2535; E-mail:
atodisco@umich.edu.
Published, JBC Papers in Press, September 19, 2001, DOI 10.1074/jbc.M009645200
 |
ABBREVIATIONS |
The abbreviations used are:
EGF, epidermal
growth factor;
MAPK, mitogen-activated protein kinase;
PI3K, phosphoinositide 3-kinase;
PKC, protein kinase C;
HA, hemagglutinin;
CMV, cytomegalovirus;
GSK3, glycogen synthase kinase 3;
PBS, phosphate-buffered saline;
Pipes, piperazine-N,N-bis[2-ethanesulfonic acid];
FITC, fluorescein isothiocyanate;
X-gal, 5-bromo-4-chloro-3-indolyl
-D-galactopyranoside;
-gal, -galactosidase.
 |
REFERENCES |
| 1.
|
Podolsky, D. K.
(1994)
in
Physiology of the Gastrointestinal Tract
(Johnson, L. R., ed), 3rd Ed.
, pp. 129-167, Raven Press, New York
|
| 2.
|
Del Valle, J.,
and Todisco, A.
(1994)
in
Textbook of Gastroenterology
(Yamada, T., ed), 3rd Ed.
, pp. 278-319, J. B. Lippincott Company, Philadelphia, PA
|
| 3.
|
Wang, L.,
Wilson, E. J.,
Osburn, J.,
and DelValle, J.
(1996)
Gastroenterology
110,
469-477[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Chew, C. S.,
Nakamura, K.,
and Petropoulos, A. C.
(1994)
Am. J. Physiol.
267,
G818-G826[Abstract/Free Full Text]
|
| 5.
|
Dembinski, A. B.,
and Johnson, L. R.
(1985)
Endocrinology
116,
90-94[Abstract/Free Full Text]
|
| 6.
|
Kaise, M.,
Muraoka, A.,
Yamada, J.,
and Yamada, T.
(1995)
J. Biol. Chem.
270,
18637-18642[Abstract/Free Full Text]
|
| 7.
|
Beauchamp, R. D.,
Barnard, J. A.,
McCutchen, C. M.,
Cherner, J. A.,
and Coffey, R. J., Jr.
(1989)
J. Clin. Invest.
84,
1017-1023
|
| 8.
|
Gooz, M.,
Hammond, C. E.,
Larsen, K.,
Mukhin, Y. V.,
and Smolka, A. J.
(2000)
Am. J. Physiol.
278,
G981-G991[Abstract/Free Full Text]
|
| 9.
|
Takeuchi, Y.,
Yamada, J.,
Yamada, T.,
and Todisco, A.
(1997)
Am. J. Physiol.
273,
G1263-G1272[Abstract/Free Full Text]
|
| 10.
|
Alessi, D. R.,
Cuenda, A.,
Cohen, P.,
Dudley, D. T.,
and Saltiel, A.
(1995)
J. Biol. Chem.
270,
27489-27494[Abstract/Free Full Text]
|
| 11.
|
Cantley, L. C.,
and Neel, B. G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4240-4245[Abstract/Free Full Text]
|
| 12.
|
Chan, T. O.,
Rittenhouse, S. E.,
and Tsichlis, P. N.
(1999)
Annu. Rev. Biochem.
68,
965-1014[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Wang, X.,
McCullough, K. D.,
Franke, T. F.,
and Holbrook, N. J.
(2000)
J. Biol. Chem.
275,
14624-14631[Abstract/Free Full Text]
|
| 14.
|
Okano, J.,
Gaslightwala, I.,
Birnbaum, M. J.,
Rustgi, A. K.,
and Nakagawa, H.
(2000)
J. Biol. Chem.
275,
30934-30942[Abstract/Free Full Text]
|
| 15.
|
Jiang, B-H.,
Aoki, M.,
Zheng, J. Z.,
Li, J.,
and Vogt, P. K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2077-2081[Abstract/Free Full Text]
|
| 16.
|
Kohn, A. D.,
Summers, S. A.,
Birnbaum, M. J.,
and Roth, R. A.
(1996)
J. Biol. Chem.
271,
31372-31378[Abstract/Free Full Text]
|
| 17.
|
Alessi, D. R.,
Andjelkovic, M.,
Caudwell, B.,
Cron, P.,
Morrice, N.,
Cohen, P.,
and Hemmings, B. A.
(1996)
EMBO J.
15,
6541-6551[Medline]
[Order article via Infotrieve]
|
| 18.
|
Franke, T. F.,
Yang, S. I.,
Chan, T. O.,
Datta, K.,
Kazlauskas, A.,
Morrison, D. K.,
Kaplan, D. R.,
and Tsichlis, P. N.
(1995)
Cell
81,
727-736[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Fujio, Y.,
Guo, K.,
Mano, T.,
Mitsuuchi, Y.,
Testa, J. R.,
and Walsh, K.
(1999)
Mol. Cell. Biol.
19,
5073-5082[Abstract/Free Full Text]
|
| 20.
|
Askari, F. K.,
Hitomi, Y.,
Mao, M.,
and Wilson, J. M.
(1996)
Gene Ther.
3,
381-388[Medline]
[Order article via Infotrieve]
|
| 21.
|
Soll, A. H.
(1978)
J. Clin. Invest.
61,
370-380
|
| 22.
|
Ljungstrom, M.,
and Chew, C. S.
(1991)
Am. J. Physiol.
260,
C67-C78[Abstract/Free Full Text]
|
| 23.
|
Campbell, V. W.,
and Yamada, T.
(1989)
J. Biol. Chem.
264,
11381-11386[Abstract/Free Full Text]
|
| 24.
|
Del Valle, J.,
Tsunoda, Y.,
Williams, J. A.,
and Yamada, T.
(1992)
Am. J. Physiol.
262,
G420-G426[Abstract/Free Full Text]
|
| 25.
|
Muraoka, A.,
Kaise, M.,
Guo, Y.,
Yamada, J.,
Song, I.,
Del Valle, J.,
Todisco, A.,
and Yamada, T.
(1996)
Am. J. Physiol.
271,
G1104-G1113[Abstract/Free Full Text]
|
| 26.
|
Takeuchi, Y.,
Pausawasdi, N.,
and Todisco, A.
(1999)
Am. J. Physiol.
276,
G1484-G1492[Abstract/Free Full Text]
|
| 27.
|
Nagahara, A.,
Wang, L.,
Del Valle, J.,
and Todisco, A.
(1998)
Am. J. Physiol.
275,
G740-G748[Abstract/Free Full Text]
|
| 28.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Smolka, A. J.,
Larsen, K. A.,
Schweinfest, C. V.,
and Hammond, C. E.
(1999)
Biochem. J.
340,
601-611
|
| 30.
|
Van Dyke, R. W.
(2000)
Hepatology
32,
1357-1369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Dufner, A.,
Andjelkovic, M.,
Burgering, B. M. T.,
Hemmings, B. A.,
and Thomas, G.
(1999)
Mol. Cell. Biol.
19,
4525-4534[Abstract/Free Full Text]
|
| 32.
|
Takaishi, H.,
Konishi, H.,
Matsuzaki, H.,
Ono, Y.,
Shirai, Y.,
Saito, N.,
Kitamura, T.,
Ogawa, W.,
Kasuga, M.,
Kikkawa, U.,
and Nishizuka, Y.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
11836-11841[Abstract/Free Full Text]
|
| 33.
|
Agnew, B. J.,
Duman, J. G.,
Watson, C. L.,
Coling, D. E.,
and Forte, J. G.
(1999)
J. Cell Sci.
112,
2639-2646[Abstract]
|
| 34.
|
Datta, S. R.,
Dudek, H.,
Tao, X.,
Masters, S.,
Fu, H.,
Gotoh, Y.,
and Greenberg, M. E.
(1997)
Cell
91,
231-241[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Doornbos, R. P.,
Theelen, M.,
van der Hoeven, P. C. J.,
van Blitterswijk, W. J.,
Verkleij, A. J.,
and van Bergen en Henegouwen, P. M. P.
(1999)
J. Biol. Chem.
274,
8589-8596[Abstract/Free Full Text]
|
| 36.
|
Murga, C.,
Laguinge, L.,
Wetzker, R.,
Cuadrado, A.,
and Gutkind, J. S.
(1998)
J. Biol. Chem.
273,
19080-19085[Abstract/Free Full Text]
|
| 37.
|
Soroka, C. J.,
Chew, C. S.,
Hanzel, D. K.,
Smolka, A.,
Modlin, I. M.,
and Goldenring, J. R.
(1993)
Eur. J. Cell Biol.
60,
76-87[Medline]
[Order article via Infotrieve]
|
| 38.
|
Wang, Q.,
Somwar, R.,
Bilan, P. J.,
Liu, Z.,
Jin, J.,
Woodgett, J. R.,
and Klip, A.
(1999)
Mol. Cell. Biol.
19,
4008-4018[Abstract/Free Full Text]
|
| 39.
|
Welch, H.,
Equinoa, A.,
Stephens, L. R.,
and Hawkins, P. T.
(1998)
J. Biol. Chem.
273,
11248-11256[Abstract/Free Full Text]
|
| 40.
|
van Weering, D. H. J.,
De Rooij, J.,
Marte, B.,
Downward, J.,
Bos, J. L.,
and Burgering, B. M. T.
(1998)
Mol. Cell. Biol.
18,
1802-1811[Abstract/Free Full Text]
|
| 41.
|
Brunet, A.,
Bonni, A.,
Zigmond, M. J.,
Lin, M. Z.,
Juo, P.,
Hu, L. S.,
Anderson, M. J.,
Arden, K. C.,
Blenis, J.,
and Greenberg, M. E.
(1999)
Cell
96,
857-868[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
del Peso, L.,
Gonzalez-Garcia, M.,
Page, C.,
Herrera, R.,
and Nunez, G.
(1997)
Science
278,
687-689[Abstract/Free Full Text]
|
| 43.
|
Cardone, M. H.,
Roy, N.,
Stennicke, H. R.,
Salvesen, G. S.,
Franke, T. F.,
Stanbridge, E.,
Frisch, S.,
and Reed, J. C.
(1998)
Science
282,
1318-1321[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Saha, C. E. Hammond, M. Gooz, and A. J. Smolka
The role of Sp1 in IL-1{beta} and H. pylori-mediated regulation of H,K-ATPase gene transcription
Am J Physiol Gastrointest Liver Physiol,
November 1, 2008;
295(5):
G977 - G986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Mettler, S. Ghayouri, G. P. Christensen, and J. G. Forte
Modulatory role of phosphoinositide 3-kinase in gastric acid secretion
Am J Physiol Gastrointest Liver Physiol,
September 1, 2007;
293(3):
G532 - G543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nitsche, S. Ramamoorthy, M. Sareban, N. Pausawasdi, and A. Todisco
Functional role of bone morphogenetic protein-4 in isolated canine parietal cells
Am J Physiol Gastrointest Liver Physiol,
September 1, 2007;
293(3):
G607 - G614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stepan, S. Ramamoorthy, H. Nitsche, Y. Zavros, J. L. Merchant, and A. Todisco
Regulation and Function of the Sonic Hedgehog Signal Transduction Pathway in Isolated Gastric Parietal Cells
J. Biol. Chem.,
April 22, 2005;
280(16):
15700 - 15708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xin, Y. T. Hou, L. Li, P. Schmiedlin-Ren, G. M. Christman, H.-L. Cheng, K. N. Bitar, and E. M. Zimmermann
IGF-I increases IGFBP-5 and collagen {alpha}1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells
Am J Physiol Gastrointest Liver Physiol,
May 1, 2004;
286(5):
G777 - G783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Pausawasdi, S. Ramamoorthy, L. J. Crofford, F. K. Askari, and A. Todisco
Regulation and function of COX-2 gene expression in isolated gastric parietal cells
Am J Physiol Gastrointest Liver Physiol,
June 1, 2002;
282(6):
G1069 - G1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|